Introduction {#Sec1}
============

For more than 40 years microsomal cytochrome *b*~5~ has been proposed to modulate the activity of cytochrome P450 enzymes, including those involved in endogenous processes such as cholesterol and steroid hormone synthesis/breakdown, as well as the metabolism of exogenous xenobiotics, chemical toxins and drugs (Akhtar et al. [@CR1]; Yamazaki et al. [@CR41]; Borthiry et al. [@CR6]; Kurian et al. [@CR23]). The modulation of P450 activity by cytochrome *b*~5~ is reported to be both substrate- and P450-specific, with evidence of both stimulation and inhibition of substrate metabolism (Yamazaki et al. [@CR41]; Schenkman and Jansson [@CR36]). Cytochrome *b*~5~ has also been described as a facilitator in the metabolism of endogenous substrates such as the desaturation of fatty acids (Jeffcoat et al. [@CR20]) and methaemoglobin reduction to haemoglobin (Jaffe [@CR19]). Importantly, for many of these pathways, cytochrome *b*~5~ has been deemed obligatory and therefore by implication possibly essential for life. However, as all the evidence to date is drawn exclusively from in vitro studies, the in vivo roles of this enzyme have thus remained speculative.

In order to address the in vivo function of microsomal cytochrome *b*~5~ in drug metabolism, we have recently generated a mouse model (hepatic *b*~5~ null (HBN)) in which microsomal cytochrome *b*~5~ was conditionally deleted in the liver (Finn et al. [@CR10]). HBN mice had significantly reduced in vitro rates of NADPH- and NADH-dependent metabolism of a range of model substrates and probe drugs; furthermore, significant changes in drug pharmacokinetics were also found, demonstrating that cytochrome *b*~5~ does indeed play a significant role in the in vivo disposition of drugs.

A conditional approach was taken in these studies because of the anticipation that complete deletion of microsomal cytochrome *b*~5~ would be embryonic lethal. However, as the functions of this protein have been based on in vitro data, we also carried out germ line deletion (*b*~5~ complete null (BCN)). Remarkably, cytochrome *b*~5~ null animals were viable, fertile and produced grossly normal pups at expected Mendelian ratios. However, cytochrome *b*~5~ null mice exhibited a number of unexpected and extraordinary phenotypes, identifying new roles for this protein in skin lipid homeostasis and neonatal development.

Materials and methods {#Sec2}
=====================

Chemicals {#Sec3}
---------

Unless stated, all reagents were purchased from Sigma--Aldrich (Poole, UK).

Cytochrome *b*~5~ complete null (BCN) mice {#Sec4}
------------------------------------------

Homozygous cytochrome *b*~5~ complete knockout mice (BCN, *Cytb*~*5*~^−*/*−^) and control (wild-type, *Cytb*~*5*~^+*/*+^) mice were generated as previously described (McLaughlin et al. [@CR29]).

All mice were maintained on a standard chow (RM1---Special Diet Services, Essex, UK) under standard animal house conditions, with free access to food and water, and 12 h light/12 h dark cycle. All animal work was carried out in accordance with the Animal Scientific Procedures Act (1986) and after local ethical review.

Tissue histology {#Sec5}
----------------

Skin sections were removed post mortem from the backs of 10 week old male wild-type and BCN mice (*n* = 3 for each genotype) and fixed flat on Whatman 3MM paper (GE Healthcare, Amersham, UK) in formal saline (Gurr^®^ BDH, VWR International, Lutterworth, UK) before being sectioned and stained with hematoxylin and eosin. Measurements were taken of the epidermis, dermis and hair shaft thickness using an Olympus IX50 microscope (Olympus UK Ltd., Watford, UK) with Zeiss Axio Vision version 4.5 software (Carl Zeiss Ltd., Welwyn Garden City, UK).

Thermal imaging {#Sec6}
---------------

Thermal imaging experiments were performed in a closed room at a constant temperature of 20°C with tolerance of 1°C and lighting kept to a minimum. This arrangement ensured temperature variations that may adversely affect the performance of the thermal camera were negligible. Temperature measurements were obtained using a high-performance thermal camera (Cedip Infrared Systems, France) containing a 320 × 240 pixel focal plane array operating in the mid-infrared range (3--5 μm) with a thermal sensitivity of 0.02°C and spatial resolution of 0.2 mm, positioned 50 cm above the subject.

Body temperature measurements of 3 week old male wild-type and BCN pups, (*n* = 3 for each genotype) were taken at the same time of the day with a 2-day interval over a period of 6 weeks to allow temperature changes to be related to growth. In order to determine skin temperature, a small area (20 mm diameter) on the back of each mouse was shaved, immediately before temperature measurements were taken. Average and maximum temperatures of the shaved and haired areas were calculated using the specialized software associated with the camera (Song et al. [@CR38]).

Mouse milking {#Sec7}
-------------

Nursing females (first litter) were milked 10 days postpartum. Briefly, mice were given an i.p. injection of oxytocin (100 μl, 5 U/ml) to simulate milk production. After 20 min, treated mice were anesthetized by inhalation of isoflurane and milk production facilitated by gentle squeezing of the nipples. The milk released was collected by pipette and samples were stored at −70°C prior to analysis.

Lipid analysis {#Sec8}
--------------

Detailed fatty acid profile analysis was performed on milk, plasma, skin and liver by the Nutrition Analytical Service, University of Stirling, UK, according to the following method. Total lipids were extracted from skin and liver by homogenising in 20 volumes of chloroform/methanol (2:1 v/v) in an Ultra Turrax tissue disrupter (Fisher Scientific, Loughborough, UK). Total lipids were prepared from all samples according to the Folch method and non-lipid impurities were removed by washing with 0.88% (w/v) KCl (Folch et al. [@CR11]). The weight of lipids was determined gravimetrically after evaporation of the solvent and overnight desiccation under vacuum. Fatty acid methyl esters (FAME) were prepared by acid-catalysed transesterification of total lipids according to the method of Christie (Christie [@CR7]). Extraction and purification of FAME was performed as described by Ghioni et al. ([@CR12]). FAME were separated and quantified by gas--liquid chromatography using a Thermo Fisher Trace GC 2000 (Thermo Fisher, Hemel Hempstead, UK) equipped with a fused silica capillary column (ZB wax, 30 m × 0.32 mm i.d.; Phenomenex, Macclesfield, UK) with hydrogen as carrier gas and using on-column injection. The temperature gradient was from 50 to 150°C at 40°C/min and then to 195°C at 1.5°C/min and finally to 220°C at 2°C/min. Individual methyl esters were identified by comparison with known standards and by reference to published data. Data were collected and processed using the Chromcard for Windows (version 2.00) computer package (Thermoquest Italia S.p.A., Milan, Italy).

Statistical analysis {#Sec9}
--------------------

Data sets were analyzed for statistical significance using an Unpaired student *t*-test ([www.graphpad.com/quickcalcs/](http://www.graphpad.com/quickcalcs/)*t-*test1.cfm).

Results and discussion {#Sec10}
======================

Global deletion of microsomal cytochrome *b*~5~ is not lethal {#Sec11}
-------------------------------------------------------------

To establish the in vivo role(s) of microsomal cytochrome *b*~5~ we generated a mouse germline deletion of exons 2--5 of the gene. Mice lacking microsomal cytochrome *b*~5~, were unexpectedly viable, born at expected Mendelian ratios and exhibited no gross anatomical abnormalities. Cytochrome *b*~5~ complete null (BCN) mice of both sexes were fertile, indicating that cytochrome *b*~5~ is not necessary for sexual maturation, demonstrating that cytochrome *b*~5~ does not play an obligatory role in testosterone biosynthesis (Akhtar et al. [@CR1]). However, analysis of testicular testosterone levels revealed that they were approximately 40% lower in BCN males and this was accompanied by the almost complete loss of the in vitro activity of Cyp17, a P450 essential for testosterone biosynthesis (McLaughlin et al. [@CR29]). In addition to its role in transferring electrons to P450s involved in the metabolism of steroids, cytochrome *b*~5~ can also act as an electron donor to P450s involved in the metabolism of drugs and foreign compounds. In agreement with our previous findings in the conditional hepatic knockout model, BCN mice also had a marked reduction in in vivo P450 drug metabolism confirming the pivotal role this protein may play in drug metabolism in vivo (Finn et al. [@CR10]; McLaughlin et al. [@CR29]).

Cytochrome *b*~5~ is thought to play a key role in the reduction of methaemoglobin to haemoglobin (Jaffe [@CR19]) and in agreement with this role, 10 week old male BCN mice had significantly higher levels of circulating methaemoglobin (tenfold) than their wild-type counterparts (Fig. S1). Methaemoglobinemia in humans is clinically defined as having methaemoglobin levels greater than 1%, with homozygous methaemoglobin reductase-deficient patients possessing levels greater than 10% (Percy et al. [@CR33]). By this definition, BCN mice are methaemoglobinemic, however none of the other physiological phenotypes associated with methaemoglobinemia due to disruption of cytochrome *b*~5~ or cytochrome *b*~5~ reductase in humans were observed (Hegesh et al. [@CR17]; Giordano et al. [@CR13]; Manabe et al. [@CR27]). These data suggest that although cytochrome *b*~5~ is part of the pathway of methaemoglobin reduction, the known alternative pathways such as the glucose/glucose-6-phosphate dehydrogenase are capable of partially compensating for loss of this protein and maintaining methaemoglobinemia at asymptomatic levels (Jaffe [@CR19]). BCN mice may, however, be more susceptible to acquired methaemoglobinemia under conditions of metabolic stress or to chemicals known to induce methaemoglobinemia (Molthrop et al. [@CR31]; Mary and Bhupalam [@CR28]).

Together these findings confirm in vivo the numerous functions assigned to microsomal cytochrome *b*~5~ through in vitro studies carried over the past four decades.

Deletion of microsomal cytochrome *b*~5~ results in the development of ichthyosis {#Sec12}
---------------------------------------------------------------------------------

Ten days after birth hair growth had commenced in wild-type mice but in contrast BCN pups remained hairless and exhibited a generalized scaling of the skin and hyperkeratosis on the tail which by 4 weeks of age resulted in development of constrictive bands, referred to as 'ringtail', a condition observed in rats kept in dry, low humidity environments (Fig. [1](#Fig1){ref-type="fig"}a, b). At 4 weeks, the hair coat of BCN mice had developed a "static" appearance and was noticeably thinner than in age-matched controls (Fig. [1](#Fig1){ref-type="fig"}c). By 10 weeks of age coat condition had improved further however, the difference in thickness compared to wild-type mice could still be clearly seen on the ventral surface (Fig. [1](#Fig1){ref-type="fig"}d). Microscopic examination of hair types from BCN and wild-type mice found no significant difference in the absolute numbers or proportion of each hair type between the two genotypes (data not shown). These data therefore suggest that deletion of microsomal cytochrome *b*~5~ delays hair follicle development.Fig. 1Characterization of skin related phenotypes from cytochrome *b*~5~ null mice. **a** 10 day old wild-type and BCN pups illustrating the scaled appearance of BCN pups. **b** A 4 week old BCN mouse demonstrating the "ringtailed" phenotype. **c** Age-matched (4 weeks) wild-type (*left*) and BCN mice demonstrating the differences in coat appearance/condition and the smaller size of the BCN mice. **d** Ventral view of 10 week old male BCN (*left*) and wild-type mice demonstrating marked thinning of the hair. **e**, **g** Hematoxylin and eosin staining of skin from 10 week old male wild-type mice, magnification 20× & 40×, respectively. **f**, **h** Hematoxylin and eosin staining of skin from 10 week old male BCN mice, magnification 20× & 40×, respectively. *Arrows* indicate the sebaceous glands (**e**--**h**) and the keratinization of the stratified squamous epithelium (**f**---*asterisked arrow*) in BCN mice. **i** Measurements of hair shaft width, epidermal and dermal thicknesses in 10 week old male BCN and wild-type mice. Values represent the mean ± SD of 50 measurements from each mouse (*n* = 3). *Black* and *white bars* represent wild-type and BCN mice respectively. \* *P* ≤ 0.05, \*\* *P* ≤ 0.005, \*\*\* *P* ≤ 0.001 comparing wild-type and BCN mice

Histological examination of dorsal skin sections from 10 week old male wild-type (Fig. [1](#Fig1){ref-type="fig"}e, g) and BCN (Fig. [1](#Fig1){ref-type="fig"}f, h) mice identified pronounced keratinization of the stratified squamous epithelium in the latter and concomitant significant thickening of the epidermis---13.2 μm ± 0.6 versus 10.2 μm ± 0.3 (Fig. [1](#Fig1){ref-type="fig"}, compare e & f). Furthermore, hair shaft width was significantly finer in BCN mice than in wild-type animals (12.7 μm ± 0.09 vs. 14.7 μm ± 0.3; Fig. [1](#Fig1){ref-type="fig"}i). Similar increases in epidermal thickness and keratinization have been reported on disruption of the 12R-lipoxygenase, *ALOX12B* locus, in mice, an enzyme involved in an alternative pathway of arachidonic acid metabolism in the skin, and suggests that cytochrome *b*~5~ may also contribute to this pathway of eicosanoid biosynthesis (Juanes et al. [@CR21]). The skin phenotypes observed in BCN mice are highly similar to those observed in the human diseases classed as autosomal recessive congenital ichthyosis (ARCI) (Akiyama and Shimizu [@CR2]).

A static hair phenotype has also been observed in stearoyl-CoA desaturase (SCD1) null mice (Miyazaki et al. [@CR30]). However, in SCD1 null mice, the effect is associated with atrophy of the sebaceous glands, as a result of lipid depletion, whereas in BCN mice the sebaceous glands were slightly enlarged (Fig. [1](#Fig1){ref-type="fig"}g, h). Also, the characteristic phenotypes associated with ichthyosis have not been reported for SCD1 null mice. These data therefore suggest a role for cytochrome *b*~5~ in lipid and eicosanoid metabolism in skin, disruption of which leads to the development of ichthyosis. Ichthyosis was not reported in the methaemoglobinemia patient identified by Hegesh et al. who expressed a splice variant of cytochrome *b*~*5*~; however this is most likely due to the presence of residual cytochrome *b*~5~ expression/activity and not complete loss as in BCN mice (Hegesh et al. [@CR17]; Giordano et al. [@CR13]).

Cytochrome *b*~5~ is essential for skin lipid homeostasis but its deletion does not disrupt epidermal barrier function {#Sec13}
----------------------------------------------------------------------------------------------------------------------

In light of the above data, we carried out fatty acid analysis of the skin. Significant changes in the levels of most saturated, monounsaturated and branched-chain fatty acid species, many of which are known to have emollient and moisturizing properties e.g. behenic and erucic acid, were observed in the skin of 10 week old male BCN mice (Table S1). In addition, significant changes in the levels of α-linolenic acid (decreased by 35%) and eicosadienoic acid (increased by 40%) were found (Table S1). Calculation of desaturation indices (i.e. the ratio of unsaturated to saturated fatty acids), as a measure of SCD activity (Attie et al. [@CR3]), for both palmitic and stearic acid showed a 50 and 54% reduction, respectively, in BCN compared to wild-type mice (Fig. [2](#Fig2){ref-type="fig"}a). This may account for some of the similarities observed between BCN and SCD1 null mice. The skin phenotype of SCD1 null mice was ascribed to the disruption of the epidermal lipid barrier, due to loss of ω-hydroxylated very long chain fatty acids and the abolishment of lymphoid enhancer-binding factor 1 (lef1) expression, a transcription factor essential for correct development of the hair follicle and the sebaceous gland; however, in agreement with the morphological differences of the sebaceous gland between BCN and SCD1 null mice, lef1 expression levels are not significantly changed in 10 week old male BCN mice (data not shown) (Binczek et al. [@CR4]; DasGupta and Fuchs [@CR9]). Members of the CYP4 family function in lipid metabolism as ω-hydroxylases, acting on long-chain fatty acids and Loughran et al. have showed that cytochrome *b*~5~ is essential for the in vitro ω-hydroxylation of arachidonic acid (Hardwick [@CR16]; Kalsotra and Strobel [@CR22]; Loughran et al. [@CR26]). The skin phenotypes observed in BCN mice may therefore result from a combination of a change in unsaturated fatty acid biosynthesis and a reduction in the ω-hydroxylation of long-chain fatty acids. In support of this possibility, Lefévre et al. have identified mutations in the gene *FLJ39501*, a member of the CYP4F subfamily, associated with lamellar ichthyosis (Lefevre et al. [@CR25]).Fig. 2Characterization of skin lipid and temperature changes in cytochrome *b*~5~ null mice. **a** Total lipid content and desaturation indices determined from skin fatty acid profile analysis carried out on 10 week old male wild-type and BCN mice. Values represent the mean ± SD, where *n* = 3 for wild-type mice and *n* = 6 for BCN mice. **b** and **c** Thermal imaging of 4 week old male wild-type and BCN mice respectively. Temperature measurements were recorded from in 3 week old wild-type and BCN mice for a period of 6 weeks as outlined in the ["Materials and methods"](#Sec2){ref-type="sec"}. **d** Average temperature and **e** maximum temperature of the haired coat area plotted against age. Values represent the mean ± SD, where *n* = 3. *Black* and *white squares* represent wild-type and BCN mice respectively. \* *P* ≤ 0.05, \*\* *P* ≤ 0.005, \*\*\* *P* ≤ 0.001 comparing wild-type and BCN mice

Approximately 30% of ARCI cases cannot be explained by genetic changes in known ichthyosis loci; the data presented here suggest that polymorphisms in the cytochrome *b*~5~ pathway represent novel candidate genes for study. The striking similarities between the BCN phenotype and the human disease suggest that the BCN mouse could potentially be a valuable genetic model for developing new treatments for this disease and suggest new approaches for therapeutic intervention.

The loss of the epidermal lipid barrier in the skin of SCD1 null mice has been associated with perturbations in temperature control (Binczek et al. [@CR4]), we therefore used thermal imaging to assess whether the changes in skin fatty acids observed in BCN mice also resulted in disruption of this barrier. A small patch of back hair was shaved on 3 week old male BCN and wild-type mice to allow skin surface temperature measurements to be recorded together with similar measurements from haired regions over a 6 week period (Fig. [2](#Fig2){ref-type="fig"}b, c). In shaved skin areas, despite significantly higher measurements at two (out of 18) time-points, no overall difference between BCN and wild-type mice in either average or maximum temperatures was detected over the 6 week period (Fig. S2). In contrast, BCN mice had consistently significantly higher average and maximum temperatures in the haired skin areas compared to wild-type mice over the entire 6 week period, however from 5 to 6 weeks of age the differences in both average and maximum temperatures between genotypes decreased and the trend was for these measurement to approach those recorded for wild-type mice (Fig. [2](#Fig2){ref-type="fig"}d, e). These data indicated that the heat losses observed in BCN mice are primarily due differences in hair coverage rather than changes in epidermal barrier permeability and confirm the visual observations that coat thickness improved with age in BCN mice.

Disruption of mammary gland cytochrome *b*~5~ activity identifies roles in the determination of milk composition and neonatal development {#Sec14}
-----------------------------------------------------------------------------------------------------------------------------------------

As indicated by the thermal imaging data, the changes in coat condition, possibly associated with the changes in skin lipid composition, improved as the mice mature, however coat condition did start to deteriorate again with age and especially in nursing females. In nursing females, this led to hair loss with skin reddening, particularly under the chin, around the eyes and snout, with the birth of each subsequent litter (Fig. [3](#Fig3){ref-type="fig"}a, b). Post-weaning, the dams' coat condition recovered and the skin inflammation subsided. Associated with these effects, pups from successive BCN litters were progressively smaller (unlike wild-type) suggesting the possibility that the dams' milk was nutritionally deficient (Fig. [3](#Fig3){ref-type="fig"}c, d). This hypothesis was supported by the finding that the fostering of BCN pups to a wild-type mother significantly reduced the growth retardation. In contrast, when wild-type pups were nursed by a BCN female a striking reduction in growth was observed (Fig. [3](#Fig3){ref-type="fig"}e, f).Fig. 3Cytochrome *b*~5~ null mice nurturing phenotype. **a** and **b** Progressive loss of coat condition in BCN females with successive litters. *Arrows* indicate the development of dry, red and inflamed skin under the chin (**a**); dry skin around eyes and muzzle, and poor coat condition accompanied by hair loss (**b**). **c** Age-matched (23 days old) BCN (*left*) and wild-type weanlings from the third litter of the relevant homozygous cross, showing the marked difference in size. **d** Time course of average litter weights for sequential litters from wild-type (*upper panel*) and BCN (*lower panel*). *Black squares*, *triangles* and *circles* represent wild-type litters 1, 2 and 3, respectively, while *white squares*, *triangles* and *circles* represent BCN litters 1, 2 and 3, respectively. Values represent the mean ± SEM. **e** Fostering of 3 day old wild-type pups (third litter) to a BCN mother and BCN pups (second litter) to a wild-type mother indicates growth retardation is due to nutrient deficiencies. **f** Growth curves for wild-type pups left with their wild-type mother (*black squares*), BCN pups fostered to the wild-type mother (*white squares*), wild-type pups fostered to a BCN mother (*black circles*) and BCN pups left with their BCN mother (*white circles*). Values represent the mean ± SEM. of *n* = 4--6. \* *P* ≤ 0.05, comparing BCN pups fostered to a wild-type mother and BCN pups left with their BCN mother. **a** *P* ≤ 0.05 and **b** *P* ≤ 0.005, comparing wild-type pups fostered to a BCN mother and wild-type pups left with their wild-type mother

The possibility that BCN milk is deficient in essential nutrients was investigated by comparing the fat content of milk taken 10 days postpartum from nursing wild-type and BCN females (both nursing their first litter). BCN milk contained a significantly higher level of total lipid; the predominant change being an increase in total saturated fatty acid levels; consistent with the role of cytochrome *b*~5~ in fatty acid desaturation (Fig. [4](#Fig4){ref-type="fig"}a, Table S2). However, a small increase in n-6 polyunsaturated fatty acids was also observed. Monounsaturated and n-3 polyunsaturated fatty acid content was unchanged. The increase in saturated fat was associated with an increase in lauric, myristic, palmitic and arachidic acid (increased by 72, 75, 56 and 67% respectively) and the increase in n-6 polyunsaturated fats was due specifically to a 32% (*P* = 0.021) increase in linoleic acid (Fig. [4](#Fig4){ref-type="fig"}b). In addition, the level of α-linolenic acid was significantly increased in BCN milk although total n-3 polyunsaturated fatty acid levels were unchanged (Fig. [4](#Fig4){ref-type="fig"}b).Fig. 4Milk fatty acid profile analysis from wild-type and cytochrome *b*~5~ null mice. Fatty acid profile analysis was carried out on milk from wild-type and BCN females nursing their first litters 10 days postpartum. **a** Total and **b** individual fatty acid levels. Values are presented as fold change relative to wild-type levels and represent the mean ± SD, where *n* = 3. \* *P* ≤ 0.05, \*\* *P* ≤ 0.005 and \*\*\* *P* ≤ 0.001 comparing wild-type and BCN mice

Under normal circumstances the level of fat contained in milk is tightly regulated but the composition can change depending on the maternal diet and circulating levels of individual fatty acids (Innis [@CR18]; Rudolph et al. [@CR35]). Genetic disruption of lactogenesis or lipogenesis, for example through the inactivation of the α-lactalbumin gene or of the activity of the mammary Akt pathway, has however been shown to increase the fat content of milk resulting in increased viscosity (Stinnakre et al. [@CR39]; Schwertfeger et al. [@CR37]). This has been suggested in both these situations to prevent pups obtaining sufficient qualities of milk to support normal growth and thus leading to growth retardation. Indeed, milk from BCN mice appeared to have increased viscosity which would be consistent with the increase in saturated fat content and could possibly lead to an inability of BCN pups to obtain sufficient nutrition to support normal growth. Cytochrome *b*~5~ may therefore be an important determinant in regulating the consistency of milk by virtue of its role in controlling fatty acid desaturation in the mammary gland.

However, we believe that the underlying reason for the reduced growth is due to a metabolic deficiency rather than a nurturing issue as the phenotype was progressive in subsequent generations. In addition to dietary intake, polyunsaturated fatty acids such as arachidonic, docosahexaenoic and eicosapentaenoic acid can be synthesised from linoleic and α-linolenic acid via the actions of Δ5 and Δ6 desaturases in maternal tissues. These desaturases have been shown to be expressed in lactating mammary glands of rats and are active in the conversion of linoleic acid to the γ-linolenic and arachidonic acid (Rodriguez-Cruz et al. [@CR34]). Additionally, the in vitro findings of Guillou et al. have shown that exogenously added cytochrome *b*~5~ is capable of enhancing Δ6 desaturase activity (Guillou et al. [@CR14]). The loss of desaturase activity could explain the increase in linoleic acid in the milk; humans genetic variations in these gene loci have been associated with altered polyunsaturated fatty acid levels in milk (Xie and Innis [@CR40]). It is therefore possible that the changes in the levels of linoleic and α-linolenic acid in BCN milk are responsible for the growth retardation observed in BCN pups. In support of this, studies in rodents have shown that excess levels of these fatty acids result in postnatal growth restriction (Bongiovanni et al. [@CR5]; Church et al. [@CR8]). The animals used in this study were on a normal diet, nutritionally balanced for saturated and unsaturated fatty acids. It is therefore intriguing that in spite of this, defects in endogenous unsaturated fatty acid biosynthesis caused the above phenotypes. The progressive degradation in the health of dams, suggests that an equilibrium exists between circulating fatty acids and breast milk, but that this is not sufficient to reverse the nutritional deficiency.

Disruption of microsomal cytochrome *b*~5~ provides evidence for a central role in mono and polyunsaturated fatty acid homeostasis {#Sec15}
----------------------------------------------------------------------------------------------------------------------------------

In support of the role of cytochrome *b*~5~ in overall fatty acid homeostasis, we found that in 16 week old male BCN mice the plasma level of γ-linolenic acid was significantly decreased (by 75%) and that of dihomo-γ-linolenic acid increased (by 153%) (Fig. [5](#Fig5){ref-type="fig"}a, Table S3). Additionally, in these mice, hepatic levels of these fatty acids followed a similar pattern with γ-linolenic acid decreased by 84% and dihomo-γ-linolenic acid increased by 195% (Fig. [5](#Fig5){ref-type="fig"}b, Table S4). Furthermore, hepatic levels of octadecatetraenoic acid were decreased by 80% and eicosatetraenoic acid increased from undetectable levels to 0.03 ± 0.01 mg/g tissue (Fig. [5](#Fig5){ref-type="fig"}b). These fatty acids correspond to the substrates and products of various reactions catalysed by the Δ5 and Δ6 desaturases (Napier et al. [@CR32]), and the differences observed in the desaturation indices for these fatty acids provides evidence for cytochrome *b*~5~ as a modulator of the activity of these enzymes (Fig. [5](#Fig5){ref-type="fig"}c, d). In view of the effects ascribed to dietary ω-3 and ω-6 fatty acids on human health, it is important to understand the role of the endogenous biosynthetic pathways on circulating levels of these unsaturated fatty acids.Fig. 5Hepatic and plasma fatty acid profile analysis in wild-type and cytochrome *b*~5~ null mice. Fatty acid profile analysis was carried out on plasma and livers from 16 week male old wild-type and BCN mice as described in the ["Materials and methods"](#Sec2){ref-type="sec"}. **a** Plasma fatty acid analysis, **b** liver fatty acid analysis, **c** plasma desaturation indices and **d** liver desaturation indices. Values are presented as fold change relative to wild-type levels and represent the mean ± SD, where *n* = 3. \* *P* ≤ 0.05, \*\* *P* ≤ 0.005 and \*\*\* *P* ≤ 0.001 comparing wild-type and BCN mice

Monounsaturated fatty acids can be obtained either from the diet or by de novo synthesis involving a cytochrome *b*~5~-dependent pathway (Hackett and Strittmatter [@CR15]; Schenkman and Jansson [@CR36]). We therefore determined saturated and monounsaturated fatty acid levels in plasma and liver from 10 and 16 week old male BCN mice (Tables S3, S4). At 16 weeks of age profound differences in both plasma and hepatic levels of stearic (increasing by 50 and 47%, respectively) and palmitoleic acid (decreasing by 34 and 52%, respectively) were observed (Fig. [5](#Fig5){ref-type="fig"}a, b). Plasma and hepatic levels of palmitic and oleic acid were effectively unchanged and only the hepatic level of palmitoleic acid was significantly changed at 10 weeks of age (Table S4). Determination of desaturation indices for both palmitic and stearic acid revealed decreases for both fatty acids in BCN mice; however, only the desaturation index for palmitic acid was significantly changed (Fig. [5](#Fig5){ref-type="fig"}c, d). These data demonstrate that under normal dietary conditions cytochrome *b*~5~-dependent pathways affect circulating mono and polyunsaturated fatty acid concentrations and their activity will therefore influence the beneficial effects of these compounds. Interestingly, Zhu et al. have recently identified a cytochrome *b*~5~/*b*~5~ reductase fusion protein, NAD(P)H cytochrome *b*~5~ oxidoreductase (Ncb5OR), located in the lumen of the endoplasmic reticulum, which when deleted in mice results in marked decreases in hepatic levels of palmitoleic and oleic acid, suggesting a role for this protein in electron transport to SCD1 (Zhu et al. [@CR42]; Larade et al. [@CR24]).

In summary, we have generated a novel genetic model that identifies the numerous and varied in vivo roles of cytochrome *b*~5~ and now allows these pathways to be studied in detail. Using this model we have identified that cytochrome *b*~5~ plays a key role in a wide range of metabolic processes of central importance to both nutrition, drug metabolism and a range of human diseases and further demonstrate the importance of de novo unsaturated fatty acid biosynthesis in human health (McLaughlin et al. [@CR29]). With the exception of the changes in hepatic lipid metabolism, none of the other phenotypic changes observed in BCN mice are seen in the conditional hepatic knockout model (Finn et al. [@CR10]). This finding indicates that these phenotypic changes are most likely due to the specific absence of cytochrome *b*~5~ in the particular tissue and not to the systematic disruption of cytochrome *b*~5~ function, a fact that would also explain, with the exception of plasma and hepatic fatty acid changes which mimic each other, the differences in fatty acid profiles obtained from different tissues. These studies also demonstrate that certain endogenous pathways of fatty acid homeostasis cannot be substituted by dietary means. The relationship between de novo biosynthesis and dietary intake of fatty acids and how dietary intervention may influence the pathogenesis of human disease will be a fascinating area of further study.
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